comparemela.com

Latest Breaking News On - Pieris pharmaceuticals inc - Page 11 : comparemela.com

Pieris Pharmaceuticals, Inc (NASDAQ:PIRS) Short Interest Update

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 67,900 shares, a decline of 63.5% from the October 31st total of 186,100 shares. Based on an average trading volume of 1,070,000 shares, […]

Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by StockNews com

StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance PIRS opened at $0.23 on Monday. The firm’s 50-day simple moving average is $0.28 and its 200-day simple moving […]

North American Morning Briefing : Stocks Seen -2- - 2023-11-15

Accord Financial 3Q Loss/Shr C$1.03; 3Q Rev C$19.4M; 3Q Adj Loss/Shr C$0.97 Almonty Industries 3Q Rev C$4.45M; 3Q Loss/Shr C$0.01 Canaccord Genuity 2Q Rev C$337.3M, Down 11% on Year; 2Q. -November 15, 2023 at 06:14 am EST - MarketScreener

Pieris Pharmaceuticals, Inc (NASDAQ:PIRS) Short Interest Down 26 7% in October

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report) saw a large drop in short interest in the month of October. As of October 31st, there was short interest totalling 186,100 shares, a drop of 26.7% from the October 15th total of 253,900 shares. Based on an average daily trading volume, of 1,710,000 shares, the short-interest […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.